In response to the COVID-19 pandemic, many companies have recently expanded or transitioned into the manufacture and distribution of products regulated by the U.S. Food and Drug Administration (FDA), including face masks, personal protective equipment (PPE), and hand sanitizer.
On Monday, August 3, 2020, President Trump issued an Executive Order directing various federal agencies to take steps advancing the adoption and availability of telehealth.
On Thursday, July 23, 2020, Department of Health and Human Services (HHS) Secretary Alex Azar officially renewed the declaration that a Public Health Emergency (PHE) exists in connection with COVID-19.
On June 30, 2020 the United States Supreme Court ruled in Patent and Trademark Office v. Booking.com B.V. that the travel website company Booking.com could register a trademark in its name BOOKING.COM.
Today, June 17, 2020, the U.S. Department of Education (DOE) published an interim final rule giving the force of law to its interpretation of the term “student” as used in the CARES Act.
Yesterday, the Department of Health and Human Services (HHS) announced two more targeted allocations of provider relief funding under the Coronavirus Aid, Relief and Economic Security (CARES) Act.
The new Presidential Proclamation does not apply to nonimmigrant temporary workers including agricultural workers who enter the U.S. on the H-2A Temporary Agricultural Worker Program.
On April 21, 2020, the Ohio Supreme Court (the Court) ruled that the primary use of a barn, rented out for various social events, including weddings, was to facilitate the sale of wine cultivated and produced on the land.
In these unforeseen and unique circumstances surrounding the Coronavirus (COVID-19) pandemic, we want to keep our clients abreast of how patent and trademark offices around the world are handling deadlines and other issues.
As widespread shortages of face masks and N95 respirators needed to help fight the COVID-19 pandemic persist, manufacturers, brokers, and other companies across the nation are looking to retool their operations for the production and sale of these crucial items.
As part of our dedication to helping our clients stay up-to-date on the ever-changing landscape as it relates to the COVID-19 pandemic, we’ve compiled the following highlights of changes to patent, trademark, and copyright operations around the world.
The U.S. Patent and Trademark Office announced on March 31, 2020 that certain patent and trademark filing and payment deadlines have been extended in response to delays caused by the COVID-19 outbreak.
In these unforeseen and unique circumstances surrounding the COVID-19 pandemic, we want to keep our clients abreast of how patent and trademark offices around the world are handling deadlines and other issues.
The wide-reaching CARES Act provides significant additional support to the health care industry inundated by the COVID-19 pandemic, primarily in the forms of new funding and regulatory relief.
HZNP Medicines LLC et al. v. Actavis Laboratories UT, Inc., No. 2017-2149 (Fed. Cir. Feb. 25, 2020) (“HZNP”) is a cautionary tale on the use of the claim term “consisting essentially of.” On October 10, 2019, a Federal Circuit panel affirmed the district court’s holding that the term “consisting essentially of” was indefinite because the patent at issue had disclosed inconsistent results to a novel property of the invention thereby rendering that novel property indefinite.
